Dong Sung Bio Pharm.Co.,Ltd. announced a private placement of 33rd unregistered coupon unguaranteed private bond with warrants for gross proceeds of KRW 14,000,000,000 on July 20, 2023. The transaction has been approved by the board of directors of the company. The transaction is expected to close on July 24, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,150 KRW | +0.19% | -0.77% | -10.59% |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding | CI |
2023 | Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-10.59% | 86.26M | |
+18.04% | 42.95B | |
+16.92% | 21.38B | |
+18.33% | 15.05B | |
+19.27% | 14.45B | |
+56.12% | 13.04B | |
-0.05% | 6.79B | |
-10.73% | 6.72B | |
-8.87% | 5.73B | |
+11.21% | 5.47B |
- Stock Market
- Equities
- A002210 Stock
- News Dong Sung Bio Pharm.Co.,Ltd.
- Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding